Researchers are exploring new strategies for controlling CAR T cells, which may lead to safer and more effective cancer immunotherapy. Various approaches are being developed, including the use of smart antibodies, fusion proteins, and automation technologies. The field of cell therapy is seeing advancements, with potential breakthroughs in treating solid tumors and other cancers, although the specifics and outcomes of these developments are not yet clear.